ROSEN, RESPECTED INVESTOR COUNSEL, Reminds Zosano Pharma Corporation Investors of Important December 28 Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact Firm – ZSAN NEW YORK, Dec. 04, 2020 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Zosano Pharma Corporation (NASDAQ: ZSAN) between February 13,...

ZSAN STOCK ALERT: Zhang Investor Law Announces Securities Class Action Lawsuit Against  Zosano Pharma Corporation – ZSAN NEW YORK, Nov. 13, 2020 (GLOBE NEWSWIRE) -- Zhang Investor Law announces a class action lawsuit on behalf of shareholders who bought shares of Zosano Pharma Corporation (NASDAQ: ZSAN) between...

ZOSANO PHARMA ALERT: Bragar Eagel & Squire, P.C. is Investigating Zosano Pharma Corp. on Behalf of Zosano Stockholders and Encourages Investors to Contact the Firm NEW YORK, Oct. 23, 2020 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Zosano Pharma Corp....

Scott + Scott, LLP Announces Investigation of Zosano Pharma Corp (ZSAN), Encourages Investors with Losses to Contact Firm NEW YORK, Sept. 29, 2016 (GLOBE NEWSWIRE) -- Scott + Scott, Attorneys at Law, LLP, a global shareholder rights litigation firm, has opened an investigation on behalf of investors in Zosano Pharma...

STOCK ALERT: Rosen Law Firm Continues to Investigate Securities Claims Against Zosano Pharma Corporation NEW YORK, May 09, 2016 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, announces that it is continuing to investigate potential securities claims on behalf of shareholders...